20 articles
New study reveals liposomal glutathione delivers dramatically superior cellular uptake and blood levels compared to standard forms.
Experts say the next era of obesity care pairs GLP-1 medications with precision medicine, endoscopic procedures, and surgery for lasting results.
Common eye-health nutrient zeaxanthin strengthens immune T cells and enhances cancer treatment effectiveness in new research.
A UC San Diego trial shows ION224 blocks liver fat production, cutting inflammation and scarring in 60% of MASH patients.
Small study reveals how exercise plus protein intake triggers beneficial gene changes in older women at metabolic risk.
New AI-discovered peptide mimics Ozempic's weight loss effects but targets only the brain's appetite center, avoiding nausea and muscle loss.
MIT researchers discover cysteine activates immune cells that boost intestinal stem cells, opening doors to nutrition-based gut therapies.
New research reveals how targeting redox balance through lifestyle changes may simultaneously prevent heart disease, cancer, and neurodegeneration.
Thomas DeLauer breaks down how microplastics cause systemic inflammation and practical detox strategies.
University of Cologne researchers reveal how the amino acid leucine boosts cellular energy by preventing breakdown of critical mitochondrial proteins.
Cutting off biotin halts cancer cell growth by disabling a key enzyme, revealing a promising new therapeutic target.
A protein thought only to burn fat secretly protects fat cell health from inside the nucleus, reshaping obesity and metabolic disease research.
Japanese scientists engineered hybrid vitamin K molecules that are 3x more potent at regrowing neurons, potentially transforming Alzheimer's treatment.
Lactarius deliciosus mushroom extracts reduced breast cancer cell survival to just 5.6% by disrupting cellular energy metabolism.
Thomas DeLauer explains how glutamine triggers neuronal autophagy for mental clarity and shares practical fasting alternatives.
Stanford researchers found genetic variants in ~10% of people that blunt GLP-1 drug effectiveness, pointing toward precision diabetes care.
New research reveals GLP-1 drugs like Ozempic deliver stronger results for 'see-food' eaters than those who eat due to stress or emotions.
Scientists found dragonflies see deep red light like humans do, opening doors for new light-based therapies that work inside the body.
New research reveals genetic 'GLP-1 resistance' affects 1 in 10 people, explaining why popular diabetes and weight-loss drugs fail for some patients.
Thomas DeLauer explains why L-serine may be more effective than vitamin C, NAC, and turmeric by boosting your body's natural antioxidant systems.
